8-K - ALX ONCOLOGY HOLDINGS INC - 5.02 / 7.01 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-152050
Filing Date: 2026-04-13
Accepted: 2026-04-13 08:35:12
Documents: 11
Period of Report: 2026-04-13
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
ALX ONCOLOGY HOLDINGS INC (Filer) CIK : 0001810182 (see all company filings) EIN. : 850642577 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 26856553 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | alxo-20260413.htm iXBRL | 8-K
2 | EX-99.1 | alxo-ex99_1.htm | EX-99.1
3 | GRAPHIC | img62044099_0.gif | GRAPHIC
4 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alxo-20260413.xsd | EX-101.SCH